Printer Friendly
The Free Library
6,671,551 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Browse Pharmaceutical industry topic

Subtopics (183)

 

Articles

1-100 out of 100 article(s)
Title Author Type Date Words
Ossulin[TM] Oral Insulin Data to be Presented at The San Francisco Diabetes Congress on November 6, 2009. Nov 6, 2009 263
King Pharmaceuticals to Present at Credit Suisse Healthcare Conference. Conference news Nov 6, 2009 336
Neurogen Corporation Announces Third Quarter 2009 Financial Results and Updates Operations. Nov 6, 2009 2705
Spectrum Pharmaceuticals Announces Date for Third Quarter 2009 Corporate Update and Pipeline Review Conference Call. Nov 6, 2009 474
Research and Markets: Johnson & Johnson: The Essential Corporate Analysis. Nov 6, 2009 280
TARIS Appoints Julie Lekstrom Himes, MD, to CMO Post. Nov 6, 2009 644
Halozyme Therapeutics Reports Third Quarter 2009 Financial Results. Financial report Nov 6, 2009 1270
Research and Markets: Brazil's Generic Medicines Continue to grow at a Higher Rate than Overall Pharmacy Sales, And Are Expected to Represent 20% Of the Sector by Volume In 2010. Nov 6, 2009 504
Research and Markets: Latest Report for the United States Pharmaceuticals and Healthcare Industry as We Find out Healthcare Spending in 2008 Reached US$2.3 Trillion. Report Nov 6, 2009 501
Graceway Pharmaceuticals Acquires Worldwide Rights to GS 9191 from Gilead Sciences. Nov 6, 2009 376
Confederation of Indian Industry and U.S.-India Business Council Announce Healthcare Partnership. Nov 6, 2009 815
Locus Pharmaceuticals Announces Focus on Drug Discovery Collaboration Business, Branded as Ansaris. Nov 6, 2009 341
Research and Markets: Consumption of Anxiolytics, Soporifics, Sedatives and Antidepressants in Portugal Increased By 32% between 2002 And 2008. Nov 6, 2009 602
United States: XOMA Granted First European Patent Covering XOMA 052. Nov 5, 2009 196
Having swallowed up Schering, Merck hungry to grow more. Nov 5, 2009 639
China : Novartis buys China vaccine stake for $125 mln. Nov 5, 2009 357
CHI Gathers Biomedical Community for the California Healthcare Policy Forum. Nov 5, 2009 62
Catalent Pharma Solutions Enters a Strategic Alliance with Endotis Pharma. Nov 5, 2009 273
BioAlliance Pharma: Epidemiological study on Oropharyngeal Candidiasis and results on miconazole MBT* compliance were presented at the 51st ASTRO Annual Meeting. Nov 5, 2009 556
Alexion to Present at Credit Suisse's 2009 Healthcare Conference. Conference news Nov 5, 2009 90
PHILIP Green is one lucky [...]. Nov 5, 2009 131
HHS Orders Intravenous Antiviral Flu Medication to Help Patients Hospitalized with 2009 H1N1. Nov 5, 2009 538
MiddleBrook Pharmaceuticals Reports Third Quarter 2009 Results. Financial report Nov 5, 2009 1492
Research and Markets: Pharmaceutical Industry in Sweden - Includes Data on Market Size and Segmentation, Key Trends and Competitive Landscape, Leading Companies & Much More. Nov 5, 2009 467
ERYtech Pharma Starts its Pivotal Clinical Trial for GRASPA[R] in Acute Lymphoblastic Leukaemia. Nov 5, 2009 407
IMS Health to be Acquired by TPG and CPP Investment Board. Nov 5, 2009 1537
Data Demonstrating Aeolus Pharmaceuticals' AEOL 10150's Efficacy as a Broad Spectrum Countermeasure Against Radiological and Chemical Threats Presented at the GHSI Public Health Emergency Medical Countermeasures Workshop. Nov 5, 2009 1180
PicksThatMove.com Announces Investment Opinion On: Mylan Laboratories Inc., Suncor Energy Inc., Romarco Minerals Inc., Nord Resources Corporation and Eastern Platinum Limited. Nov 5, 2009 656
Aureus Pharma Extends Its Knowledge Database Agreement with Sanofi-Aventis R&D. Nov 5, 2009 363
Dynavax Appoints Francis R. Cano, Ph.D. to Board of Directors. Nov 5, 2009 272
Inspire Reports Third Quarter 2009 Financial Results. Nov 5, 2009 2090
Biovail Declares Quarterly Dividend. Nov 5, 2009 195
Biovail Reports Third-Quarter 2009 Financial Results. Financial report Nov 5, 2009 4422
Alnylam Presents New Pre-Clinical Data on RNAi Therapeutics at Oligonucleotides Therapeutics Society (OTS) Meeting. Nov 5, 2009 1574
Aradigm Announces Third Quarter 2009 Financial Results. Financial report Nov 5, 2009 709
King Pharmaceuticals Reports Strong Third Quarter 2009 Financial Results. Financial report Nov 5, 2009 1693
Ligand's JAK3 Research Collaboration Extended by Pfizer. Nov 5, 2009 589
ARIAD Reports Third Quarter 2009 Development Progress and Financial Results. Financial report Nov 5, 2009 1527
Columbia Laboratories Reports Third Quarter 2009 Financial Results. Nov 5, 2009 1817
Salix Pharmaceuticals to Present at Credit Suisse Conference. Conference news Nov 4, 2009 314
Salix Pharmaceuticals to Host Analyst Day on November 18. Nov 4, 2009 500
Antigenics Provides Details On GlaxoSmithKline's Pivotal Malaria Vaccine Trial With QS-21 Adjuvant. Nov 4, 2009 611
Inspire Completes Patient Enrollment in Three Late-Stage Clinical Trials in Cystic Fibrosis, Dry Eye and Blepharitis. Nov 4, 2009 1244
Alnylam and Roche Advance RNAi Therapeutic Collaboration Phase of Landmark 2007 Alliance. Nov 4, 2009 1001
Acacia Subsidiary Authorizes McKesson to Use Document Generation Technology. Nov 4, 2009 294
CPEX Pharmaceuticals Reports Third-Quarter 2009 Financial Results. Financial report Nov 4, 2009 1504
SuperGen to Present at Merriman Curhan Ford Investor Summit on November 10, 2009. Nov 4, 2009 140
Thirteen Abstracts Featuring Exelixis Compounds Accepted for Presentation at the 2009 AACR-NCI-EORTC International Conference. Conference news Nov 4, 2009 800
Arrowhead Subsidiary Calando Pharmaceuticals Expands Board of Directors. Nov 4, 2009 865
Research and Markets: Pharmaceutical Industry in the Netherlands - Economic Trends, Competition, Key Players, SWOT Analysis of Leading Companies & Much More. Nov 4, 2009 471
Research and Markets: Pharmaceutical Industry in Denmark - Economic Trends, Competition, Key Players, SWOT Analysis of the Leading Companies & Much More. Nov 4, 2009 466
Synta Pharmaceuticals Reports Third Quarter 2009 Financial Results. Nov 4, 2009 1229
Opexa Therapeutics Reports Third Quarter 2009 Financial Results and Corporate Update. Financial report Nov 4, 2009 1796
Emisphere Technologies Announces Third Quarter 2009 Conference Call. Nov 4, 2009 423
Lannett Company to Report Fiscal 2010 First-Quarter Financial Results and Host Conference Call on Monday, November 9, 2009. Nov 4, 2009 181
GTx, Inc. Announces Third Quarter 2009 Corporate Results Conference Call and Webcast. Nov 4, 2009 147
Acceleron Pharma Initiates First-in-Human Study of ACE-041, a Novel Angiogenesis Inhibitor, in Patients with Advanced Cancer. Nov 4, 2009 586
New Merck Begins Operations. Nov 4, 2009 1657
AGA Medical Receives Product Approvals in China. Nov 4, 2009 870
Affymax[R] Reports Third Quarter 2009 Financial Results. Financial report Nov 4, 2009 435
Flamel Technologies Announces Licensing Agreement with Pfizer. Nov 4, 2009 420
Javelin Pharmaceuticals to Announce Third Quarter 2009 Financial Results. Financial report Nov 4, 2009 342
Research and Markets: Leading Indian Companies Have Developed Infrastructure in Over 60 Countries Including Developed Markets Like US and Europe Says PEST Framework Analysis. Nov 4, 2009 255
Pro-Pharmaceuticals Closes $310,000 Tranche; Brings Total to $4.1 Million of $6.0 Million Private Placement. Nov 4, 2009 624
BioAlliance Pharma Presents Additional US Pivotal Phase III Results on Loramyc[TM] (Miconazole Lauriad[R]) at the 47Th Annual Meeting of the IDSA. Nov 4, 2009 498
Aeolus Pharmaceuticals' AEOL 10150 Protects Lungs Against Chlorine Gas Exposure in Animal Studies. Nov 4, 2009 939
Alkermes' Corporate Presentation to be Webcast at the Credit Suisse Healthcare Conference. Conference news Nov 4, 2009 147
Fitch Downgrades Merck and Upgrades Schering-Plough to 'A+' Following Merger; Outlook Stable. Nov 4, 2009 1116
NPS Pharmaceuticals Reports Third Quarter Results and Improved Cash Burn Guidance. Financial report Nov 4, 2009 1887
Philadelphia VIP Sponsors Free Legal Clinic for Small Businesses Provided by Volunteer Corporate Counsel. Nov 4, 2009 373
Neurogen Corporation Announces Webcast of Third Quarter 2009 Financial Results on November 6. Nov 4, 2009 151
China: Novartis invests $1 bln in China R&D plant. Nov 4, 2009 94
India: Novartis Venture Funds Eyes India Deals. Nov 4, 2009 531
British flu drug firms under fire in US for 'price fixing'. Nov 4, 2009 131
Germany : German Pharamaceutical Merck Acquires Bulgarian Aquachim. Nov 3, 2009 349
Pakistan : Czech Republic to initiate joint ventures with Pakistan. Nov 3, 2009 394
United States: Quintiles Announces Clinical Pharmacology Alliance with AstraZeneca. Clinical report Nov 3, 2009 371
United States: ART Advanced Research Technologies Inc. Secures Up to $1.2 Million in Interim Financing. Nov 3, 2009 203
Daily Wrap Up - Nov 3. Financial report Nov 3, 2009 362
India : Caraco looking at shifting production to India. Nov 2, 2009 307
India : Suven Life Sciences, Gammon India & Pyramid Saimira Q2 results. Financial report Nov 2, 2009 228
Japan : ICON Selected by Lilly to Oversee its Clinical Data Management in Japan. Nov 2, 2009 283
Nigeria: U.S. $75 Million - Pfizer Demands DNA Report From Beneficiaries. Nov 2, 2009 523
Netherlands : European pharmaceutical industry continues to invest in technology. Industry overview Nov 2, 2009 135
New Zealand: NZTA to establish national ticketing system for public transport. Nov 2, 2009 478
United States: Pharmaceutical firm uses solar energy to go green. Nov 2, 2009 194
United states : Amylin and Takeda to develop and commercialize pharmaceutical products for obesity. Nov 2, 2009 446
United states : GTx To Provide Update On Pending Toremifene New Drug Application. Nov 2, 2009 197
United states : Sosei and ASKA Pharmaceuticals sign distribution agreement. Nov 2, 2009 223
United States : Medpace Inc. Expands Therapeutic Capabilities With the Acquisition of Pharma. Nov 2, 2009 361
United States : Optimer Pharmaceuticals presents additional data from Phase 3 fidaxomicin study. Nov 2, 2009 274
United States : Idenix Pharmaceuticals Presents Data On IDX184 For The Treatment Of Hepatitis C Virus (HCV). Clinical report Nov 2, 2009 456
United States : U.S. Food And Drug Administration Issues Complete Response Letter Regarding PEGINTRON(R) For Malignant Melanoma. Nov 2, 2009 443
United States : Daiichi Sankyo, JK Tyre & Financial Tech Q2 result. Nov 2, 2009 518
South Africa: Aurobindo Pharma receives two new registration from MCC. Nov 2, 2009 130
A donut hole filled with drug-industry pork. Peters, Charles Nov 1, 2009 210
SHL wins operational excellence award for quality from Amgen. Oct 27, 2009 235
What's up, doc? Risk management issues in promotional practices to physicians. Quinley, Kevin Oct 1, 2009 1368
Pharmaceutical patents: incentives for research and development or marketing? Brekke, Kurt R.; Straume, Odd Rune Oct 1, 2009 13191
Pharmaceutical bar coding: moving forward in Canada. Sheppard, Ian; Hyland, Sylvia; Leonard, Pierrette; Koczmara, Christine Sep 22, 2009 2195

Terms of use | Copyright © 2009 Farlex, Inc. | Feedback | For webmasters | Submit articles